Physician profile
Floyd C Watson
NPI 1447268164
$1,597.99
in general payments reported to CMS, 2019-2025
19 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $96.62 · 2021: $278 · 2022: $284 · 2023: $206 · 2024: $295 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $315.15 | 2019-2022 | |
| Pfizer INC. | $272.81 | 2019-2025 | |
| Lilly USA, LLC | $145.14 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Merck Sharp & Dohme LLC | $139.43 | 2019-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Dexcom, INC. | $138.53 | 2022-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $98.87 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $71.54 | 2022-2023 | Vraylar |
| Novartis Pharmaceuticals Corporation | $58.70 | 2021 | |
| Exact Sciences Corporation | $49.16 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbott Laboratories | $44.49 | 2021-2022 | |
| Organon LLC | $41.85 | 2025 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $40.22 | 2024-2025 | Breztri |
| Novo Nordisk INC | $33.55 | 2021-2022 | |
| Axsome Therapeutics, INC. | $33.18 | 2025 | Auvelity |
| Cipher Pharmaceuticals US LLC | $32.07 | 2025 | Natroba, Spinosad |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.95 | 2021-2024 | Jardiance |
| Averitas Pharma INC. | $22.18 | 2025 | Qutenza |
| Sanofi Pasteur INC. | $15.73 | 2025 | |
| Exeltis, USA INC. | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floyd Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.